Intercept Pharmaceuticals Says Settlement Reached With Amneal Pharmaceuticals Over Ocaliva Generic | Aici



MT Newswires 2023

All news about INTERCEPT PHARMACEUTICALS, INC.

Analyst Recommendations on INTERCEPT PHARMACEUTICALS, INC.

Auctions for 2022 316 M

Total revenue for 2022 35.8 M

Balance for 2022 61.9 m

P/E ratio 2022 29, 9x
2022 harvest
Capitalization 768 m
768 m
EV / Sales 2022 2.23x
EV / Sales 2023 2.35x
Nbr of employees 437
Free-Float 96.8%

Chart INTERCEPT PHARMACEUTICALS, INC.


Time frame :

Time :




Intercept Pharmaceuticals, Inc Chart MarketScreener

Technical analysis trends INTERCEPT PHARMACEUTICALS, INC.

Short term In the meantime Long term
Trends Bullish Neutrality Neutrality

Income Statement Evolution

Sell ​​it

Buy it

It means compromise HOLD ON
No. of Analysts 16
Final Closing Amount $18.55
Average target value 22,50 $
Distribution Target / Rate 21.3%




Source link

Leave a Reply

Your email address will not be published. Required fields are marked *